Glial Fibrillary Acidic Protein (GFAP) (N-Term) Peptide
Quick Overview for Glial Fibrillary Acidic Protein (GFAP) (N-Term) Peptide (ABIN977365)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- FSLAGALNAG FKETRASERA EMMELNDRFA SYIEKVRFLE QQNKALAAEL
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Gfap Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- GFAP (Glial Fibrillary Acidic Protein (GFAP))
-
Background
-
GFAP, a class-III intermediate filament, is a cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells.
Alias Symbols: AI836096
Protein Interaction Partner: Nr2e1,Ncor1,Stat1,Ubc
Protein Size: 418 -
Molecular Weight
- 46 kDa
-
Gene ID
- 14580
-
NCBI Accession
- NM_010277, NP_034407
-
UniProt
- P03995
Target
-